FY2025 · period end Dec '25 · from the 10-K filed Mar 11, 2026
| Metric | FY25Dec '25 | FY24Dec '24 |
|---|---|---|
| Revenue | $1.45B | $1.23B |
| Gross Profit | $0.29B | $0.24B |
| Operating Income | $0.07B | negative: -$0.06B |
| Net Income | $0.05B | negative: -$0.11B |
| EPS (Diluted) | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 |
|---|---|---|
| Total Assets | $0.41B | $0.32B |
| Total Liabilities | $0.19B | $0.17B |
| Stockholders' Equity | $0.22B | $0.15B |
| Cash & Equivalents | $0.07B | $0.00B |
| Total Debt | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 |
|---|---|---|
| Operating Cash Flow | $0.10B | $0.06B |
| Capital Expenditures | — | — |
| Free Cash Flow | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 |
|---|---|---|
| Gross Margin | 20.2% | 19.9% |
| Operating Margin | 0.1% | negative: -0.1% |
| Net Margin | 0.0% | negative: -0.1% |
| Return on Equity | 26.8% | negative: -73.4% |
| Return on Assets | 13.4% | negative: -34.3% |
| Debt / Equity | — | — |
Showing the most recent 2 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 10-Q | 0001193125-26-338074 | Jun 30, 2026 | Aug 6, 2026 | Aug 6, 2026 20:17 UTC | EDGAR |
| 8-K | 0001193125-26-338032 | Aug 6, 2026 | Aug 6, 2026 | Aug 6, 2026 20:12 UTC | EDGAR |
| 8-K | 0001193125-26-277596 | Jun 22, 2026 | Jun 22, 2026 | Jun 22, 2026 20:35 UTC | EDGAR |
| 8-K | 0001193125-26-245235 | May 21, 2026 | May 28, 2026 | May 28, 2026 20:11 UTC | EDGAR |
| 8-K | 0001193125-26-211924 | May 5, 2026 | May 7, 2026 | May 7, 2026 20:12 UTC | EDGAR |
| 8-K | 0001193125-26-208989 | May 6, 2026 | May 6, 2026 | May 6, 2026 20:13 UTC | EDGAR |
| 10-Q | 0001193125-26-209021 | Mar 31, 2026 | May 6, 2026 | May 6, 2026 20:16 UTC | EDGAR |
| 8-K | 0001193125-26-119772 | Mar 18, 2026 | Mar 23, 2026 | Mar 23, 2026 20:19 UTC | EDGAR |
Direct links to SEC EDGAR. GRDN has additional filings available on the SEC site.
Who is buying and selling Guardian Pharmacy Services, Inc. — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on GRDN yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on GRDN and publish the result to your public profile.
Ask about Guardian Pharmacy Services, Inc.
Continue in Workspace — cited answers on GRDN, a thesis you can score, or a signal on the next filing.
Open in WorkspaceGet 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs